Claudin proteins in ovarian cancer

Disease Markers

Volumn 23, Issue 5-6, 2007, Pages 453-457

  Morin, Patrice J ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 3; CLAUDIN 4; ENTEROTOXIN;

CANCER DIAGNOSIS; CANCER THERAPY; CLOSTRIDIUM PERFRINGENS; DRUG BINDING; GENE TECHNOLOGY; HUMAN; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

CLOSTRIDIUM PERFRINGENS;

EID: 36549025937     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2007/674058     Document Type: Review

References (40)

1. K. Wang, L. Gan, E. Jeffery, M. Gayle, A.M. Gown, M. Skelly, P.S. Nelson, W.V. Ng, M. Schummer, L. Hood and J. Mulligan, Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray, Gene 229 (1999), 101-108.
2. C.D. Hough, C.A. Sherman-Baust, E.S. Pizer, F.J. Montz, D.D. Im, N.B. Rosenshein, K.R. Cho, G.J. Riggins and P.J. Morin, Large-Scale Serial Analysis of Gene Expression Reveals Genes Differentially Expressed in Ovarian Cancer, Cancer Res 60 (2000), 6281-6287.
3. P.J. Morin, Claudin proteins in human cancer: promising new targets for diagnosis and therapy, Cancer Res 65 (2005), 9603-9606.
4. S. Tsukita and M. Furuse, Pores in thewall: claudins constitute tight junction strands containing aqueous pores, J Cell Biol 149 (2000), 13-16.
5. S. Tsukita, M. Furuse and M. Itoh, Multifunctional strands in tight junctions, Nat Rev Mol Cell Biol 2 (2001), 285-293.
6. K.J. Hewitt, R. Agarwal and P.J. Morin, The claudin gene family: expression in normal and neoplastic tissues, BMC Cancer 6 (2006), 186.
7. B.M. Gumbiner, Breaking through the tight junction barrier, J Cell Biol 123 (1993), 1631-1633.
8. R.S. Weinstein, F.B. Merk and J. Alroy, The structure and function of intercellular junctions in cancer, Adv Cancer Res 23 (1976), 23-89.
9. J.M. Mullin, Potential interplay between luminal growth factors and increased tight junction permeability in epithelial carcinogenesis, J Exp Zool 279 (1997), 484-489.
10. T.A. Martin and W.G. Jiang, Tight junctions and their role in cancer metastasis, Histol Histopathol 16 (2001), 1183-1195.
11. L.B.A. Rangel, R. Agarwal, T. D'Souza, E.S. Pizer, P.L. Alò, W.D. Lancaster, L. Gregoire, D.R. Schwartz, K.R. Cho and P.J. Morin, Tight Junction Proteins Claudin-3 and Claudin-4 Are Frequently Overexpressed in Ovarian Cancer but Not in Ovarian Cystadenomas, Clin Cancer Res 9 (2003), 2567-2575.
12. Y. Zhu, M. Brannstrom, P.O. Janson and K. Sundfeldt, Differences in expression patterns of the tight junction proteins, claudin 1, 3, 4 and 5, in human ovarian surface epithelium as compared to epithelia in inclusion cysts and epithelial ovarian tumours, Int J Cancer 118 (2006), 1884-1891.
13. A.D. Santin, F. Zhan, S. Bellone, M. Palmieri, S. Cane, E. Bignotti, S. Anfossi, M. Gokden, D. Dunn, J.J. Roman, T.J. O'Brien, E. Tian, M.J. Cannon, J. Shaughnessy, Jr. and S. Pecorelli, Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy, Int J Cancer 112 (2004), 14-25.
14. K. Hibbs, K.M. Skubitz, S.E. Pambuccian, R.C. Casey, K.M. Burleson, T.R. Oegema, Jr., J.J. Thiele, S.M. Grindle, R.L. Bliss and A.P. Skubitz, Differential gene expression in ovarian carcinoma: identification of potential biomarkers, Am J Pathol 165 (2004), 397-414.
15. V.A. Heinzelmann-Schwarz, M. Gardiner-Garden, S.M. Henshall, J. Scurry, R.A. Scolyer, M.J. Davies, M. Heinzelmann, L.H. Kalish, A. Bali, J.G. Kench, L.S. Edwards, P.M. Vanden Bergh, N.F. Hacker, R.L. Sutherland and P.M. O'Brien, Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer, Clin Cancer Res 10 (2004), 4427-4436.
16. K.H. Lu, A.P. Patterson, L. Wang, R.T. Marquez, E.N. Atkinson, K.A. Baggerly, L.R. Ramoth, D.G. Rosen, J. Liu, I. Hellstrom, D. Smith, L. Hartmann, D. Fishman, A. Berchuck, R. Schmandt, R. Whitaker, D.M. Gershenson, G.B. Mills and R.C. Bast, Jr., Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis, Clin Cancer Res 10 (2004), 3291-3300.
17. E. Bignotti, R.A. Tassi, S. Calza, A. Ravaggi, C. Romani, E. Rossi, M. Falchetti, F.E. Odicino, S. Pecorelli and A.D. Santin, Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy, Gynecol Oncol 103 (2006), 405-416.
18. J.J. Stewart, J.T. White, X. Yan, S. Collins, C.W. Drescher, N.D. Urban, L. Hood and B. Lin, Proteins associated with Cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels, Mol Cell Proteomics 5 (2006), 433-443.
19. Y. Soini and A. Talvensaari-Mattila, Expression of claudins 1, 4, 5, and 7 in ovarian tumors of diverse types, Int J Gynecol Pathol 25 (2006), 330-335.
20. L.B.A. Rangel, C.A. Sherman-Baust, R.P. Wernyj, D.R. Schwartz, K.R. Cho and P.J. Morin, Characterization of Novel Human Ovarian Cancer-Specific Transcripts (HOSTs) Identified by Serial Analysis of Gene Expression, Oncogene (2003), in press.
21. R. Agarwal, T. D'Souza and P.J. Morin, Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity, Cancer Res 65 (2005), 7378-7385.
22. Y. Chen, Q. Lu, E.E. Schneeberger and D.A. Goodenough, Restoration of tight junction structure and barrier function by down- regulation of the mitogen-activated protein kinase pathway in ras- transformed Madin-Darby canine kidney cells, Mol Biol Cell 11 (2000), 849-862.
23. T. Soma, H. Chiba, Y. Kato-Mori, T. Wada, T. Yamashita, T. Kojima and N. Sawada, Thr(207) of claudin-5 is involved in size-selective loosening of the endothelial barrier by cyclic AMP, Exp Cell Res 300 (2004), 202-212.
24. T. D'Souza, R. Agarwal and P.J. Morin, Phosphorylation of claudin-3 at threonine 192 by cAMP-dependent protein kinase regulates tight junction barrier function in ovarian cancer cells, J Biol Chem 280 (2005), 26233-26240.
25. M. Tanaka, R. Kamata and R. Sakai, EphA2 phosphorylates the cytoplasmic tail of Claudin-4 and mediates paracellular permeability, J Biol Chem 280 (2005), 42375-42382.
26. D.G. Rosen, L. Wang, J.N. Atkinson, Y. Yu, K.H. Lu, E.P. Diamandis, I. Hellstrom, S.C. Mok, J. Liu and R.C. Bast, Jr., Potential markers that complement expression of CA125 in epithelial ovarian cancer, Gynecol Oncol 99 (2005), 267-277.
27. B. Davidson, Z. Zhang, L. Kleinberg, M. Li, V.A. Florenes, T.L. Wang and M. Shih Ie, Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from diffuse malignant peritoneal mesothelioma, Clin Cancer Res 12 (2006), 5944-5950.
28. A.M. Tokes, J. Kulka, S. Paku, A. Szik, C. Paska, P.K. Novak, L. Szilak, A. Kiss, K. Bogi and Z. Schaff, Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study, Breast Cancer Res 7 (2005), R296-305.
29. Y. Usami, H. Chiba, F. Nakayama, J. Ueda, Y. Matsuda, N. Sawada, T. Komori, A. Ito and H. Yokozaki, Reduced expression of claudin-7 correlates with invasion and metastasis in squamous cell carcinoma of the esophagus, Hum Pathol 37 (2006), 569-577.
30. M.B. Resnick, T. Konkin, J. Routhier, E. Sabo and V.E. Pricolo, Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study, Mod Pathol 18 (2005), 511-518.
31. H. Miyamori, T. Takino, Y. Kobayashi, H. Tokai, Y. Itoh, M. Seiki and H. Sato, Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases, J Biol Chem 276 (2001), 28204-28211.
32. P. Dhawan, A.B. Singh, N.G. Deane, Y. No, S.R. Shiou, C. Schmidt, J. Neff, M.K. Washington and R.D. Beauchamp, Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer, J Clin Invest 115 (2005), 1765-1776.
33. N. Oku, E. Sasabe, E. Ueta, T. Yamamoto and T. Osaki, Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1, Cancer Res 66 (2006), 5251-5257.
34. P. Michl, C. Barth, M. Buchholz, M.M. Lerch, M. Rolke, K.H. Holzmann, A. Menke, H. Fensterer, K. Giehl, M. Lohr, G. Leder, T. Iwamura, G. Adler and T.M. Gress, Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer, Cancer Res 63 (2003), 6265-6271.
35. T. Hoevel, R. Macek, K. Swisshelm and M. Kubbies, Reexpression of the TJ protein CLDN1 induces apoptosis in breast tumor spheroids, Int J Cancer 108 (2004), 374-383.
36. S. Offner, A. Hekele, U. Teichmann, S. Weinberger, S. Gross, P. Kufer, C. Itin, P.A. Baeuerle and B. Kohleisen, Epithelial tight junction proteins as potential antibody targets for pancarcinoma therapy, Cancer Immunol Immunother 54 (2005), 431-445.
37. J. Katahira, H. Sugiyama, N. Inoue, Y. Horiguchi, M. Matsuda and N. Sugimoto, Clostridium perfringens enterotoxin utilizes two structurally related membrane proteins as functional receptors in vivo, J Biol Chem 272 (1997), 26652-26658.
38. P. Michl, M. Buchholz, M. Rolke, S. Kunsch, M. Lohr, B. McClane, S. Tsukita, G. Leder, G. Adler and T.M. Gress, Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin, Gastroenterology 121 (2001), 678-684.
39. H. Long, C.D. Crean, W.H. Lee, O.W. Cummings and T.G. Gabig, Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium, Cancer Res 61 (2001), 7878-7881.
40. A.D. Santin, S. Cane, S. Bellone, M. Palmieri, E.R. Siegel, M. Thomas, J.J. Roman, A. Burnett, M.J. Cannon and S. Pecorelli, Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridiumperfringens enterotoxin, Cancer Res 65 (2005), 4334-4342.